Statistically Prioritized and Contextualized Clinical Decision Support Systems, the Future of Adverse Drug Events Prevention?


Journal

Studies in health technology and informatics
ISSN: 1879-8365
Titre abrégé: Stud Health Technol Inform
Pays: Netherlands
ID NLM: 9214582

Informations de publication

Date de publication:
16 Jun 2020
Historique:
entrez: 24 6 2020
pubmed: 24 6 2020
medline: 25 8 2020
Statut: ppublish

Résumé

Clinical decision support systems (CDSS) fail to prevent adverse drug events (ADE), notably due to over-alerting and alert-fatigue. Many methods have been proposed in the literature to reduce over-alerting of CDSS: enhancing post-alert medical management, taking into account user-related context, patient-related context and temporal aspects, improving medical relevance of alerts, filtering or tiering alerts on the basis of their strength of evidence, their severity, their override rate, or the probability of outcome. This paper analyzes the different options, and proposes the setup of SPC-CDSS (statistically prioritized and contextualized CDSS). The principle is that, when a SPC-CDSS is implemented in a medical unit, it first reuses actual clinical data, and searches for traceable outcomes. Then, for each rule trying to prevent this outcome, the SPC-CDSS automatically estimates the conditional probability of outcome knowing that the conditions of the rule are met, by retrospective secondary use of data. The alert can be turned off below a chosen probability threshold. This probability computation can be performed in each medical unit, in order to take into account its sensitivity to context.

Identifiants

pubmed: 32570470
pii: SHTI200247
doi: 10.3233/SHTI200247
doi:

Types de publication

Journal Article

Langues

eng

Pagination

683-687

Auteurs

Emmanuel Chazard (E)

Univ. Lille, CHU Lille, CERIM EA2694, F-59000 Lille, France.

Jean-Baptiste Beuscart (JB)

Univ. Lille, CHU Lille, CERIM EA2694, F-59000 Lille, France.

Michaël Rochoy (M)

Univ. Lille, CERIM EA2694, General practitioner, F-59000 Lille, France.

Olivia Dalleur (O)

Pharmacy Department, Université catholique de Louvain, 1200, Brussels, Belgium.

Bertrand Decaudin (B)

Univ. Lille, CHU Lille, EA7365 GRITA, F-59000 Lille, France.

Pascal Odou (P)

Univ. Lille, CHU Lille, EA7365 GRITA, F-59000 Lille, France.

Grégoire Ficheur (G)

Univ. Lille, CHU Lille, CERIM EA2694, F-59000 Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH